Rostral neuropore
The Rostral Neuropore is a crucial structure in the early development of the embryo. It is the anterior opening that forms during the early stages of neural tube development. The rostral neuropore eventually closes, which is a critical process in the formation of the central nervous system.
Development[edit]
The rostral neuropore forms during the third week of human embryonic development. It is one of the two openings of the neural tube, the other being the caudal neuropore. The rostral neuropore is located at the cranial or head end of the embryo, while the caudal neuropore is at the tail end.
The closure of the rostral neuropore is a complex process that involves the coordinated movement and proliferation of neural crest cells. This process is usually completed by the 25th day of embryonic development. The exact mechanisms that regulate the closure of the rostral neuropore are still not fully understood, but it is known that it involves a combination of cellular proliferation, migration, and apoptosis.
Clinical Significance[edit]
Failure of the rostral neuropore to close properly can lead to a number of serious neural tube defects, including anencephaly and encephalocele. These conditions are characterized by the absence or malformation of parts of the brain and skull, and they can be fatal or cause severe neurological impairment.
Prenatal diagnosis of these conditions is possible through the use of ultrasound and maternal serum alpha-fetoprotein screening. If detected early, some neural tube defects can be corrected through fetal surgery, although this is a complex and risky procedure.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
